Codexis, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 1.19 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 130.31M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Details
| Name | Codexis, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 146 |
| Founded | 2002 |
| Ipo Date | 2010-04-22 |
| Ceo | Alison Moore |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US1920051067 |
| Cusip | 192005106 |
| Cik | 0001200375 |
| Sic | 2860 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Alison Moore Ph.D. | President, Chief Executive Officer and Director |
| Georgia L. Erbez | Chief Financial Officer and Chief Business Officer |
| Dr. Stefan Lutz Ph.D. | Chief Scientific Officer |
| Britton Jimenez | Senior Vice President of Sales and Marketing |
| Karen Frechou-Armijo | Senior Vice President and Head of Human Resources |
| John Schiffhauer | Senior Vice President of Intellectual Property |
Contact
| Address | 200 Penobscot Drive, Redwood City, California 94063, United States |
| Phone | 650 421 8100 |
| Website | https://www.codexis.com |